课题基金 / 基金详情

项目摘要

项目成果

DAVID Alan MEAD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): A post-antibiotic era of multiple drug resistance has begun to threaten the health and well-being of mankind. A crucial limitation in economically converting untapped natural product potential to final scalable production is the lack of next-generation tools to effectively access the full medicinal impact of natural environments. This project utilizes innovative technologies to capture entire small molecule pathways and express them for the first time in E. coli, resulting in a potent pipeline of novel environmentally-derived therapeutic compounds. There are two unique components available to achieve this goal: 1) A new strain of engineered E. coli to support many of the unique building blocks needed for expression of natural product biosynthetic pathways and 2) A BAC library of 800 clones containing entire small molecule pathways up to 170 kb to be assayed for expression of anti-bacterial activities against the ESKAPE series of pathogens. The outcomes of this research are expected to significantly accelerate the discovery and production of novel antimicrobial compounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
High Fidelity Linear MicroVector to Clone Complex, Problematic, and Large DNAs
  • 批准号:
    9346284
  • 项目类别:
  • 资助金额:
    $22.43万
  • 财政年份:
    2017
  • 负责人:
    DAVID Alan MEAD
  • 依托单位:
Analytical Metagenomics Paradigm for Structure Based Screening
  • 批准号:
    8310684
  • 项目类别:
  • 资助金额:
    $16.38万
  • 财政年份:
    2012
  • 负责人:
    DAVID Alan MEAD
  • 依托单位:
Enabling Technologies for Low Resource Molecular Diagnostics
  • 批准号:
    8044040
  • 项目类别:
  • 资助金额:
    $20.0万
  • 财政年份:
    2010
  • 负责人:
    DAVID Alan MEAD
  • 依托单位:
Enabling Technologies for Low Resource Molecular Diagnostics
  • 批准号:
    7779226
  • 项目类别:
  • 资助金额:
    $20.0万
  • 财政年份:
    2010
  • 负责人:
    DAVID Alan MEAD
  • 依托单位:
海外基金